CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS

Incidence  of vulvar cancer  in reproductive patients and  peculiarities  of clinical course of the disease  have been  studied. 839  vulvar cancer  patients aged  20-90 years have been treated at Gynecology Department of Rostov Research Oncologic Institute within the latest 30 years. The reproducti...

Full description

Bibliographic Details
Main Authors: G. A. Nerodo, E. M. Nepomnyashaya, E. A. Nerodo
Format: Article
Language:English
Published: Bashkir State Medical University 2017-01-01
Series:Креативная хирургия и онкология
Subjects:
Online Access:https://www.surgonco.ru/jour/article/view/137
_version_ 1797872412601090048
author G. A. Nerodo
E. M. Nepomnyashaya
E. A. Nerodo
author_facet G. A. Nerodo
E. M. Nepomnyashaya
E. A. Nerodo
author_sort G. A. Nerodo
collection DOAJ
description Incidence  of vulvar cancer  in reproductive patients and  peculiarities  of clinical course of the disease  have been  studied. 839  vulvar cancer  patients aged  20-90 years have been treated at Gynecology Department of Rostov Research Oncologic Institute within the latest 30 years. The reproductive group  (20-50 years of age)  included 64 patients (7,6%). Early stages of vulvar cancer in the reproductive group were diagnosed more often than in elderly patients. Neurodystrophic changes of vulvar in young patients were much rarely observed in comparison with elderly patients. Almost 80% of patients under 40 years of age had human papilloma  virus; in the  group  of 41-50  years of age  – 50%; whereas in the  elderly group contamination with  human papilloma  virus was  observed only in single cases  – 0,48%. Organ-sparing operations performed by strict individual approach are possible in the group of young  patients. Vulvar cancer, in particular with advanced malignant process, requires complex   treatment  including   neoadjuvant  and   multi-course adjuvant  chemotherapy. Recurrent disease in reproductive patients is observed less frequent than in elderly patients. Chemotherapy is appropriate in cases of recurrent disease in order to improve  operability.
first_indexed 2024-04-10T00:59:27Z
format Article
id doaj.art-505ca1d8be0d406fa8f3a29c20b53333
institution Directory Open Access Journal
issn 2307-0501
2076-3093
language English
last_indexed 2024-04-10T00:59:27Z
publishDate 2017-01-01
publisher Bashkir State Medical University
record_format Article
series Креативная хирургия и онкология
spelling doaj.art-505ca1d8be0d406fa8f3a29c20b533332023-03-13T10:01:06ZengBashkir State Medical UniversityКреативная хирургия и онкология2307-05012076-30932017-01-0103616610.24060/2076-3093-2012-0-3-61-66137CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTSG. A. Nerodo0E. M. Nepomnyashaya1E. A. Nerodo2Ростовский Научно-исследовательский онкологический институтРостовский Научно-исследовательский онкологический институтРостовский Научно-исследовательский онкологический институтIncidence  of vulvar cancer  in reproductive patients and  peculiarities  of clinical course of the disease  have been  studied. 839  vulvar cancer  patients aged  20-90 years have been treated at Gynecology Department of Rostov Research Oncologic Institute within the latest 30 years. The reproductive group  (20-50 years of age)  included 64 patients (7,6%). Early stages of vulvar cancer in the reproductive group were diagnosed more often than in elderly patients. Neurodystrophic changes of vulvar in young patients were much rarely observed in comparison with elderly patients. Almost 80% of patients under 40 years of age had human papilloma  virus; in the  group  of 41-50  years of age  – 50%; whereas in the  elderly group contamination with  human papilloma  virus was  observed only in single cases  – 0,48%. Organ-sparing operations performed by strict individual approach are possible in the group of young  patients. Vulvar cancer, in particular with advanced malignant process, requires complex   treatment  including   neoadjuvant  and   multi-course adjuvant  chemotherapy. Recurrent disease in reproductive patients is observed less frequent than in elderly patients. Chemotherapy is appropriate in cases of recurrent disease in order to improve  operability.https://www.surgonco.ru/jour/article/view/137рак вульвымолодой возрастклиническое течение
spellingShingle G. A. Nerodo
E. M. Nepomnyashaya
E. A. Nerodo
CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
Креативная хирургия и онкология
рак вульвы
молодой возраст
клиническое течение
title CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
title_full CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
title_fullStr CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
title_full_unstemmed CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
title_short CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS
title_sort clinical course of vulvar cancer in reproductive patients
topic рак вульвы
молодой возраст
клиническое течение
url https://www.surgonco.ru/jour/article/view/137
work_keys_str_mv AT ganerodo clinicalcourseofvulvarcancerinreproductivepatients
AT emnepomnyashaya clinicalcourseofvulvarcancerinreproductivepatients
AT eanerodo clinicalcourseofvulvarcancerinreproductivepatients